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Replication stress induces mitotic death through
parallel pathways regulated by WAPL and telomere
deprotection
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Mitotic catastrophe is a broad descriptor encompassing unclear mechanisms of cell death.
Here we investigate replication stress-driven mitotic catastrophe in human cells and identify
that replication stress principally induces mitotic death signalled through two independent
pathways. In p53-compromised cells we find that lethal replication stress confers WAPL-
dependent centromere cohesion defects that maintain spindle assembly checkpoint-
dependent mitotic arrest in the same cell cycle. Mitotic arrest then drives cohesion fatigue
and triggers mitotic death through a primary pathway of BAX/BAK-dependent apoptosis.
Simultaneously, a secondary mitotic death pathway is engaged through non-canonical telo-
mere deprotection, regulated by TRF2, Aurora B and ATM. Additionally, we find that sup-
pressing mitotic death in replication stressed cells results in distinct cellular outcomes
depending upon how cell death is averted. These data demonstrate how replication stress-
induced mitotic catastrophe signals cell death with implications for cancer treatment and
cancer genome evolution.
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Inducing genotoxic stress is a common mechanism of actionfor frontline chemotherapeutics. Overwhelming a cell’s capa-city to cope with exogenous DNA damage results in lethality
through activation of regulated cell death pathways such as
apoptosis1. Cell death in response to genotoxic stress is more
pronounced in actively dividing cells, which imparts the clinical
efficacy of genotoxic agents on proliferative cancers. Consistent
with the link between proliferation and lethality, many genotoxic
agents are associated with cell death during mitosis2. Pathways of
mitotic death fall under the broad classification of mitotic
catastrophe3.
Mitotic catastrophe is a regulated onco-suppressive mechanism
that responds to aberrant mitoses by removing damaged cells
from the cycling population4. This can occur through cell death
or permanent growth arrest. Whilst mitotic catastrophe has been
described for some time, there is no clear understanding of the
pathway(s) regulating mitotic death3. Nevertheless, evidence
suggests that mitotic catastrophe is a mechanism of cell death
during chemotherapeutic intervention, and that developing
resistance to mitotic death would impart a selective advantage to
neoplastic cells5.
Many genotoxic agents directly or indirectly induce replication
stress6. Replication stress is broadly defined as the slowing or
inhibition of DNA replication. This includes endogenous stress
originating from oncogene expression, and repetitive and/or
secondary DNA structures, or exogenous stress from pharma-
cological agents that induce DNA damage, reduce nucleotide
production, or inhibit DNA polymerases6,7. Difficulties arising
during DNA replication often manifest as mitotic abnormalities,
including chromosome segregation errors, anaphase- or ultra-fine
bridges, micronuclei, and the passage of replication stress-
induced DNA damage through mitosis8–11. While replication
stress is implicated as a driver of mitotic catastrophe, mechanisms
of replication stress-induced cell death remain unclear.
Here we investigated the cellular response of human primary
and cancer cells to pharmacologically induced DNA replication
stress with a specific focus on cell lethality. We observed that high
dosages of replication stress inducing drugs resulted in mitotic
bypass and proliferative arrest without lethality in p53-competent
primary fibroblasts. Conversely, in p53-compromised fibroblasts
and cancer cells, lethal replication stress induces a striking out-
come of spindle assembly checkpoint (SAC)-dependent mitotic
arrest and cell death principally conferred during mitosis. We
found this mitotic death resulted from two independent pathways
engaged during mitotic arrest. A primary pathway regulated by
wings apart-like protein homologue (WAPL) that drove cohesion
fatigue and BAX/BAK-mediated intrinsic apoptosis, and a sec-
ondary pathway signalled through non-canonical telomere
deprotection. Together, these data reveal functions for WAPL
and telomeres in sensing replication-stress induced damage and
executing mitotic death, with implications for cancer therapy
and cancer genome evolution.
Results
Replication stress induces SAC-dependent mitotic arrest. To
visualize replication stress-induced lethality, we treated human
cells with escalating doses of Aphidicolin (APH) or Hydroxyurea
(HU) and visualized the outcomes with live-cell imaging (Sup-
plementary Movie 1). APH inhibits family B DNA polymerases,
whereas HU inhibits ribonucleotide reductase to limit the
nucleoside pool available for nascent DNA synthesis. Cultures
were visualized after drug treatment with differential interference
contrast (DIC) microscopy every 6 min for up to 65 h (Fig. 1a).
Qualitative results indicated a strong mitotic arrest and mitotic
death phenotype. We therefore measured mitotic duration from
nuclear envelope breakdown to mitotic exit or mitotic death, and
classified mitotic outcomes as normal, death, multipolar cell
division (mitosis resulting in more than two daughter cells), or
mitotic slippage (transition from mitosis to interphase without
cell division) (Fig. 1b).
In primary IMR90 fibroblasts, APH or HU treatment induced a
marked reduction in mitotic entry and proliferative arrest
(Fig. 1c–e and Supplementary Fig. 1a). The p53 pathway confers
growth arrest in response to genomic insult12, suggesting p53
may prevent mitotic entry in replication stressed cells. In
agreement, inhibiting p53 and Rb in IMR90 cells through
exogenous expression of HPV16 E6 and E7 (IMR90 E6E7)
resulted in a significant increase in mitotic duration and mitotic
death with escalating dosages of APH and HU (Fig. 1c, d). Two-
dimensional data representation revealed that mitoses which died
arose after 20 h of APH or HU treatment, and that mitotic death
correlated with increased mitotic duration (Fig. 1f and Supple-
mentary Fig. 1a). IMR90-hTERT cultures expressing the
dominant negative p53DD allele also depicted similar mitotic
arrest and mitotic death with delayed kinetics in response to
lethal APH (Supplementary Fig. 1b, c). We also transduced
IMR90 cultures with lentivectors expressing Cas9 and gRNAs
targeting p53 and sorted for transduced cells. Analysis of p53
CRISPR targeted populations revealed reduced p53 protein levels
and corresponding increases in mitotic duration and mitotic
death with APH treatment (Supplementary Fig. 1d–g). Inhibiting
p53 is therefore required for replication stress-induced mitotic
death in IMR90 cells.
p53-compromised cancer cells also exhibited mitotic arrest and
mitotic death with lethal replication stress. HT1080 6TG are a
p53 mutant derivative of the HT1080 fibrosarcoma cell line.
Treating HT1080 6TG cultures with escalating concentrations of
APH and HU revealed concomitant significant increases in
mitotic duration and mitotic death (Fig. 1g, h). Mitotic events
resulting in death started 20 h after 1 µM APH, or 30 h after 500
µM HU treatment, and correlated with increased mitotic duration
(Fig. 1i and Supplementary Fig. 2a). HeLa cervical carcinoma and
p53-null Saos-2 osteosarcoma cells also exhibited increased
mitotic duration and mitotic death when treated with lethal
dosages of APH (Supplementary Fig. 2b, c).
Correlation between mitotic duration and death suggested that
mitotic arrest drives replication stress lethality. The SAC is
regulated by MPS1 kinase and arrests mitosis until tension is
established across the mitotic spindle13. We tested SAC
involvement in replication stress-induced mitotic arrest by
performing live cell imaging of HT1080 6TG cultures treated
with APH or HU, and the MPS1 inhibitor reversine14. Reversine
suppressed mitotic arrest and death, consistent with mitotic arrest
being a key determinant of replication stress lethality (Fig. 1j–l
and Supplementary Fig. 2d). Additionally, rescuing mitotic death
with reversine conferred an increase in multipolar cell division in
APH treated cells and mitotic slippage in HU treated cultures
(Fig. 1k).
Replication stress induces death in the same cell cycle. Mitotic
death in multiple p53-compromised cell lines required twenty or
more hours of APH or HU treatment. To determine if replication
stress-induced lethality occurred in the same or subsequent cell
cycle, we created fluorescent, ubiquitination-based cell cycle
indicator (FUCCI) expressing HT1080 6TG cultures15 (Fig. 2a).
HT1080 6TG-FUCCI cells were treated with APH or DMSO and
visualized with DIC and fluorescent live cell imaging every 6 min
for up to 60 h (Supplementary Movie 2). Cells were scored for G1
and S/G2 duration, respectively, by mCherry-hCdt1(30/120) and
mVenus-hGeminin(1/110) stability. Mitotic duration and
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outcomes were classified as described above, with the addition of
mitotic bypass, defined as transition from G2 [mVenus-hGemi-
nin(1/110) expressing] to G1 [mCherry-hCdt1(30/120) expres-
sing] without mitotic entry (Fig. 2a). We also scored interphase
cell death (Fig. 2a).
Asynchronous HT1080 6TG-FUCCI cells displayed a stratified
response to APH treatment characterized by cell cycle phase at
the time of drug administration. Cells in S/G2 phase when APH
was added to the media, and which remained in S/G2 for <20 h
with APH, displayed little to no mitotic arrest or cell death
phenotype (Fig. 2b, c). Conversely, cells in S/G2 phase when APH
was added to the media, and which remained in S/G2 for >20 h
with APH, displayed common mitotic arrest and mitotic death in
the same cell cycle (Fig. 2b, c). APH did not impact G1 duration
(Fig. 2d). However, when cells exited G1 in the presence of APH
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mitotic death all in the same cell cycle (Fig. 2b, d). Notably, 85%
of cell death events in HT1080 6TG-FUCCI cells observed in the
first cell cycle with APH treatment occurred during mitosis
(Fig. 2e). Cumulatively, these data indicate lethal replication stress
administered early in S-phase predominantly kills cells in the
immediately following mitosis.
To determine if persistent APH treatment during mitotic arrest
impacts mitotic death, we imaged HT1080 6TG-FUCCI cells
during APH treatment and following washout of the drug from
the growth media. Cells were cultured with 1 µM APH for 30 h
before media removal and replacement with culture media
containing DMSO or fresh 1 µM APH (Supplementary Fig. 3a).
Notably, APH washout failed to rescue lethality in cells already
arrested in mitosis (Supplementary Fig. 3b). Additionally, for 2 h
after APH removal, cells continued to enter mitosis, arrest and die
(Supplementary Fig. 3b). Mitotic arrest and death thus did not
result from persistent APH treatment during cell division.
Indicating instead that an outcome induced by lethal replication
stress, prior to mitotic entry, confers the subsequent arrest and
mitotic death.
Replication stress induces p53-dependent mitotic bypass. To
determine how replication stress impacted cell cycle progression
in p53-competent primary fibroblasts, we live-cell imaged IMR90
FUCCI cultures. APH treatment of IMR90-FUCCI cells induced
an extended S/G2, mitotic bypass, and growth arrest in pre-
sumably tetraploid G1-phase cells (Supplementary Fig. 3c). This
is consistent with p53-activation from a genomic DNA damage
response (DDR) being sufficient to induce mitotic bypass and
proliferative arrest16,17. We note APH treated IMR90 FUCCI cells
often displayed what appeared as a sustained G1-arrest without S-
phase entry (Supplementary Fig. 3c), likely reflecting early S-
phase arrest when mCherry-hCdt1(30/120) remains stable. p53
thus prevents mitotic entry, and therefore mitotic death, in
replication stress stressed IMR90 cultures. For the remainder of
this study we focused on mitotic death in p53-compromised cells.
Replication stress induces distinct types of mitotic death. The
specific contribution of cell death pathways in mitotic catastrophe
remains poorly understood3. BAX and BAK are BCL-2 family
proteins essential for apoptosis through their role in mitochon-
drial outer membrane permeabilization (MOMP)18,19. Using
CRISPR-Cas9 we generated clonal HeLa and HT1080 6TG BAX
and BAK double knock out (BAX BAK DKO) cell lines (Sup-
plementary Fig. 4a). Parental and BAX BAK DKO cells were
treated with APH and visualized with live cell imaging. APH
induced mitotic arrest in BAX BAK DKO cultures, with indivi-
dual mitotic events exhibiting a longer duration mitotic arrest
than observed in parental cells (Fig. 3a, b and Supplementary
Fig. 4b–d). Of note, BAX BAK DKO rescued most, but not all,
mitotic death in APH treated cultures at the cost of increased
multipolar cell division and mitotic slippage (Fig. 3c and Sup-
plementary Fig. 4e).
Observation of apoptosis-dependent and -independent mitotic
death suggested the potential for multiple mitotic death initiating
events occurring simultaneously in response to replication stress.
To assess this possibility, we imaged live cultures of H2B-
mCherry expressing HT1080 6TG cultures treated with a lethal
dose of APH. These experiments revealed two chromosome
phenotypes associated with replication stress-induced mitotic
death (Fig. 3d and Supplementary Movie 3). Type 1 mitotic death
was defined by a dispersion of chromosomal material immedi-
ately preceding lethality, whereas Type 2 mitotic death was
defined by the collapse or condensation of the genetic material
without chromosome dispersion (Fig. 3d). Type 1 mitotic death
was the dominant outcome in both 0.75 and 1.0 µM APH treated
cultures, followed by Type 2 mitotic death, with a minor
percentage of interphase lethality occurring exclusively in the
1.0 µM APH treated cells (Fig. 3e).
Replication stress induces WAPL-dependent cohesion fatigue.
We characterized the chromosome phenotypes associated with
mitotic death by preparing cytogenetic chromosome preparations
from APH or HU treated HT1080 6TG cultures (Fig. 4a, b and
Supplementary Fig. 5a, b). This revealed a major phenotype of
aberrant chromosome cohesion induced by replication stress
(Fig. 4b, c and Supplementary Fig. 5b). We sub-classified the
cohesion abnormalities as a mild phenotype defined by visible
separation of sister centromeres; a moderate phenotype of
cohesion loss between sister centromeres and the adjacent chro-
mosomal region, with cohesion remaining at distal chromosome
arms; and a severe phenotype of complete sister chromatid
separation (Fig. 4b). Replication stress also induced entangled
chromosomes consistent with condensation defects (Supple-
mentary Fig. 5a)20.
The mild and moderate cohesion phenotypes initiated from the
centromeres (Fig. 4b), suggesting involvement of microtubule
pulling forces driving chromatid separation. We tested this by
treating cells with a lethal dose of APH or HU in combination
with colcemid or Taxol to inhibit microtubule dynamics, or
reversine to silence the SAC (Fig. 4a). In APH and HU treated
cells, Taxol, colcemid, and reversine all suppressed the moderate
and severe cohesion phenotype (Fig. 4c and Supplementary
Fig. 5b). These observations are consistent with cohesion fatigue,
a phenomena where sustained microtubule pulling forces exerted
during mitotic arrest drive unscheduled chromosome segregation
prior to anaphase onset21,22. We interpret these data to indicate
Fig. 1 Replication stress induces mitotic arrest and mitotic death. a Time course of live cell imaging throughout this study unless indicated otherwise.
b Representative images depicting mitotic outcome and duration from DIC live cell imaging experiments. Time is shown as (hours: minutes) relative to
the first image of the series. Scale bar represents 10 µm. c Mitotic duration of IMR90 or IMR90 E6E7 cells following treatment with Dimethyl sulfoxide
(DMSO) vehicle, Aphidicolin (APH), or Hydroxyurea (HU) (three biological replicates scoring n≥ 46 mitoses per condition for IMR90 or n≥ 66 mitoses
per condition for IMR90 E6E7 are compiled in a Tukey box plot, Mann–Whitney test). d Outcome of the mitotic events in (c) (mean ± s.e.m, n= 3
biological replicates, Fisher’s Exact Test). e, f Two-dimensional dot plots for IMR90 (e) and IMR90 E6E7 (f) of mitotic duration and outcome for the data
shown in (c, d). Each symbol represents an individual mitosis. T= 0 h is when DMSO or APH were added to the culture. Location of a symbol on the x-axis
indicates the time after treatment when that mitosis initiated, the height on the y-axis represents mitotic duration, and the symbol corresponds to mitotic
outcome. g Mitotic duration of HT1080 6TG cells following treatment with DMSO, APH, or HU (three biological replicates scoring n≥ 92 mitotic events
per condition compiled in a Tukey box plot, Mann–Whitney test). h Outcome of the mitotic events in (g) (mean ± s.e.m, n= 3 biological replicates, Fisher’s
Exact Test). i Two-dimensional dot plots of mitotic duration and outcome from (g, h). jMitotic duration of HT1080 6TG cultures treated with DMSO, APH
or HU ± reversine (REV) (three biological replicates scoring≥ 112 mitotic events per each condition compiled in a Tukey box plot, Mann–Whitney test).
k Outcome of mitotic events in (j) (mean ± s.e.m., n= 3 biological replicates, Fisher’s Exact Test). l Two-dimensional plots of mitotic duration and outcome
from (j, k). For all panels, *p < 0.05, **p < 0.01. Source data are provided as a Source Data file
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the moderate and severe conditions represent a phenotypic
continuum of cohesion fatigue as sister chromatids are progres-
sively separated during mitotic arrest. Conversely, the mild
cohesion phenotype was not impacted by reversine, Taxol or
colcemid, indicating instead that the mild phenotype results from
replication stress, but not mitotic arrest nor microtubule-
dependent forces. Chromosome entanglement occurred in all
replication stress conditions (Fig. 4c and Supplementary
Fig. 5a–c). However, the complexity of entangled chromosomes
prevented classification of cohesion status and was excluded from
subsequent analysis.
WAPL is a cohesion antagonist that regulates opening of the
cohesion DNA exit gate to enable dynamic interaction between
cohesion and chromatin23,24. Depleting WAPL increases cohesin
retention on chromatin and suppresses cohesion fatigue21,24,25.
To probe for WAPL involvement in the replication stress-induced
cohesion phenotypes, we siRNA depleted WAPL, treated cultures
with a lethal dose of APH or HU, and assayed chromosome
cohesion in cytogenetic chromosome preparations (Fig. 4d–g and
Supplementary Fig. 5c). We observed in APH and HU treated
HT1080 6TG cultures that WAPL depletion suppressed both the
moderate and severe sister chromatid cohesion phenotypes
e
1 μM APHDMSOb

















































0:00 0:06 0:18 0:30 0:54
Mitotic
death
0:00 0:30 5:36 6:24 6:42
Multipolar
cell division
0:00 1:24 1:54 2:06 2:12
Interphase
cell death
0:00 2:00 4:06 4:24 4:36
Mitotic
bypass







































Cells in G1 when treated
DMSO 1 μM APH





















Fig. 2 Replication stress induces mitotic death in the same cell cycle. a Representative images from live cell microscopy of HT1080 6TG-FUCCI cells. Time
is shown as (h:min) relative to the first image of the series. Scale bars represent 10 µm. b Cell fate map of HT1080 6TG-FUCCI live cell imaging. Each bar
represents an individual cell as it progresses through the first cell cycle to cell division or death, relative to addition of DMSO (n= 127) or APH (n= 148) to
the growth media at T= 0. Segment length represents the duration a cell spent in each cell cycle phase. Cell cycle phases are colour coded according to
FUCCI and shown in the legend. Data are from two independent biological replicates compiled into a single graph. c, d Cell cycle phase duration and
outcome for HT1080 6TG-FUCCI live cell imaging shown in (b). Data are sorted based on cells that were in S/G2 (c) or G1 (d) at the time the DMSO or
APH was administered. Symbols indicate if a cell survived that cell cycle phase and progressed, or if the cell died during that cell cycle phase. Data are from
two independent biological replicates, compiled into a dot plot (Mann–Whitney test, **p < 0.01, ns= not significant). e Categorization of all cell death
events from (b) in the first cell cycle with APH treatment (n= 2 replicates, line represents the mean). Source data are provided as a Source Data file
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dependent upon mitotic arrest, and the mitotic arrest-
independent minor cohesion phenotype (Fig. 4f–g and Supple-
mentary Fig. 5c).
Type 1 mitotic death is WAPL and BAX/BAK dependent. We
also assayed the impact of WAPL depletion on replication stress-
induced mitotic lethality. Concomitant with rescue of the cohe-
sion phenotypes, WAPL depletion significantly reduced mitotic
duration and rescued mitotic death in HT1080 6TG cultures
treated with 1 µM APH or 350 µM HU (Fig. 5a, b and Supple-
mentary Fig. 6a, b). This was not an artefact of reduced pro-
liferation, as APH and HU treated cells continued to enter mitosis
in WAPL depleted cultures (Supplementary Fig. 6c). Similarly,
WAPL depletion in 1 µM APH treated HeLa cultures significantly
reduced mitotic duration and mitotic death at the cost of a sig-
nificant increase in multipolar cell divisions (Supplementary
Fig. 6d, e).
As both WAPL depletion and BAX BAK DKO rescued most of
the mitotic death induced by replication stress, we reasoned that
WAPL and BAX/BAK may function in the same pathway. To test
this, we created HT1080 6TG H2B-mCherry BAX BAK DKO cells
(Supplementary Fig. 6f). We then treated HT1080 6TG H2B-
mCherry, WAPL depleted HT1080 6TG H2B-mCherry, or
HT1080 6TG H2B-mCherry BAX BAK DKO cells with 1 µM
APH and visualized mitotic outcomes with live cell imaging
(Fig. 5c, d and Supplementary Fig. 6g). WAPL depletion
completely suppressed Type 1 mitotic death with no significant
effect on Type 2 mitotic or interphase death (Fig. 5d). Similarly,
BAX BAK DKO also largely suppressed Type 1 mitotic death with
no significant effect on Type 2 mitotic or interphase death
(Fig. 5d). Together, these data indicate that Type 1 mitotic death
is WAPL and BAX/BAK dependent.
Rescuing mitotic death results in distinct outcomes. Addi-
tionally, we quantified how suppressing mitotic death in HT1080
6TG H2B-mCherry cells impacted cellular outcomes. In the
absence of replication stress, WAPL depletion induced a slight
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Fig. 3 Replication stress induces distinct types of mitotic death. a Mitotic duration of HeLa parental and BAX BAK DKO cells following treatment with
DMSO or APH (three biological replicates using independent clones scoring n≥ 32 mitotic events per condition are compiled in a Tukey box plot,
Mann–Whitney test, **p < 0.01, ns= not significant). b Two-dimensional dot plots of mitotic duration and outcome in 0.75 µM APH treated HeLa parental
and BAX BAK DKO cells from (a). The dashed line identifies the longest duration mitosis observed in the parental cells. c Outcome of the mitotic events in
(a) (mean ± s.e.m., n= 3 biological replicates using independent clones, Fisher’s Exact Test, **p < 0.01, ns= not significant). d Representative images of
Type 1 and Type 2 mitotic death in 1 µM APH treated HT1080 6TG H2B-mCherry cells. Time is shown as (h:min) relative to the first image of the series.
Scale bar represents 10 µm. e Quantitation of cell death events in 0.75 and 1.0 µM APH treated HT1080 6TG H2B-mCherry cultures (mean ± s.d., n= 3
biological replicates scoring ≥57 mitotic events per condition for 0.75 µM APH and n= 4 biological replicates scoring ≥91 mitotic events per condition for
1.0 µM APH). Source data are provided as a Source Data file
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(6.0% ± 2.4 of mitoses, Supplementary Fig. 6g). However, when
combined with 1 µM APH, WAPL depletion conferred a sub-
stantial increase in multipolar cell division or mitoses resulting
in micronuclei formation (47.2% ± 2.8 of mitoses, Fig. 5d)26.
Alternatively, APH treatment in HT1080 6TG H2B-mCherry
BAX BAK DKO cells induced a significant increase in mitotic
slippage (Fig. 5d).
An explanation for these distinct outcomes is that WAPL and
BAX/BAK function sequentially in the Type 1 mitotic death
pathway. Data presented above suggests that WAPL functions
upstream to regulate mitotic arrest and cohesion fatigue, whereas
the known BAX/BAK function in MOMP19 is consistent with
BAX/BAK functioning downstream in apoptotic induction.
Depleting WAPL in BAX BAK DKO cells suppressed mitotic
duration in APH treated cultures, consistent with WAPL
promoting upstream mitotic arrest (Fig. 5e, f). Assaying
cohesion in APH treated BAX BAK DKO cells revealed a specific
increase in mitoses with the severe cohesion phenotype (Fig. 5g),
consistent with a downstream inability to clear mitoses
following complete cohesion fatigue. Close examination using
live-cell confocal microscopy of 1 µM APH treated H2B-mCherry
BAX BAK DKO cells revealed a striking outcome of multi-lobular
nuclei accompanying mitotic slippage (Supplementary Movie 4).
We expect this occurs as result of the improper nuclear
packaging of fully separated sister chromatids. Remnants of
chromosome segregation errors persisted after 1 µM APH was
applied to cultures for 2 days, removed, and cells allowed
to propagate for one additional day, with multilobular
nuclei significantly more enriched in BAX BAK DKO cells
(Fig. 5h–j).
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Fig. 4 Replication stress induces WAPL-dependent cohesion fatigue. a Time course for experimentation in (b, c). b Representative images of cytogenetic
chromosome spreads depicting the replication stress-induced cohesion phenotypes from HT1080 6TG cells stained with DAPI (blue), centromere (red)
and telomere (green) FISH. c Quantitation of cohesion phenotypes depicted in (b) in HT1080 6TG cells treated with DMSO or APH, ± reversine (REV),
colcemid or Taxol (mean ± s.e.m., n= 3 biological replicates scoring≥ 152 chromosome spreads per condition, Fisher’s Exact Test). d Experimental time
course for (e–g). e Western blots of whole cell extracts from HT1080 6TG cells treated with WAPL or control siRNA. f Representative images of
cytogenetic chromosome spreads from HT1080 6TG cells treated with APH and siRNA. g Quantitation of cohesion phenotypes in HT1080 6TG cells
treated with APH ± siRNA (mean ± s.e.m., n= 3 biological replicates scoring≥ 144 chromosome spreads per condition, Fisher’s Exact Test). For all panels
**p < 0.01. Scale bars represent 10 µm. Source data are provided as a Source Data file
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Replication stress induces mitotic telomere deprotection. To
address potential mechanisms contributing to the minor Type 2
mitotic death pathway, we assayed DDR activation on cytocen-
trifuged mitotic chromatin following treatment with lethal
dosages of APH or HU (Fig. 6a, b). Surprisingly, we observed
similar numbers of genomic and telomeric γ-H2AX foci on
mitotic chromosomes from APH and HU treated cells (Fig. 6c).
Telomeres represent a minor proportion of the total genome,
suggesting induction of a telomere-specific phenotype with lethal
replication stress. One possibility is that exogenous replication
stress disproportionally impacts the difficult to replicate repetitive
G-rich telomeric DNA sequence27–29. Replication stress in ver-
tebrate telomeres is attenuated through the telomere-specific
TRF1 protein29.
To investigate potential contribution of telomere replication
stress to mitotic lethality, we over-expressed mCherry-TRF1
(mCherry-TRF1OE) in HT1080 6TG cells (Fig. 6d). Surprisingly,
mCherry-TRF1OE failed to reduce the number of mitotic
H2B-mCherry
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telomere DDR foci observed with APH treatment (Fig. 6e, f).
mCherry-TRF1OE also failed to impact mitotic duration or confer
a survival advantage to cells treated with 1 µM APH (Fig. 6g, h).
Together this indicates that the mitotic outcomes observed with
lethal APH treatment are independent of replication stress within
the telomeric DNA.
Alternatively, the mitotic telomere DDR accompanying lethal
replication stress could arise through non-canonical telomere
deprotection (Supplementary Fig. 7a)30. Canonical telomere
function is to mediate chromosome end protection and regulate
cell aging as a function of telomere length31. However, telomere-
specific DDR activation also occurs through a non-canonical
pathway during prolonged mitotic arrest30. Mitotic arrest-
dependent telomere deprotection is regulated by the Aurora B
kinase and the telomere-specific TRF2 protein30. During mitotic
arrest in human cells, TRF2 dissociates from chromosome ends
resulting in a telomere macromolecular structural change from
telomere-loops (t-loops) to linear telomeres30,32. This exposes the
chromosome end as an ATM substrate to activate the mitotic
telomere DDR32.
To test for mitotic arrest-dependent telomere deprotection
we treated HT1080 6TG cells with lethal dosages of APH or
HU in combination with the SAC inhibitor reversine, the
Aurora B inhibitor Hesperadin, or the ATM inhibitor KU-
55933 (Fig. 6i, j)33,34. Consistent with non-canonical mitotic
telomere deprotection, the telomere DDR induced by lethal
replication stress was suppressed by inhibiting Aurora B, ATM,
or mitotic arrest (Fig. 6j and Supplementary Fig. 7b). Reversine
and Hesperadin did not reduce genomic DDR foci induced by
APH or HU, indicating the reduced number of telomeric
γ-H2AX foci did not result from global DDR suppression
(Fig. 6i, j and Supplementary Fig. 7b). KU-55933 did reduce
genomic DDR foci induced by APH or HU, consistent with the
global role for ATM in DDR signalling. Additionally, no
telomere shortening occurred with the telomere DDR in 1 µM
APH treated cells, (Fig. 6k), consistent with telomere length
independent non-canonical deprotection30. We note that
mitotic telomere deprotection occurred in parallel with
cohesion fatigue as we observed DDR-positive telomeres in
mitoses with completely separated sister chromatids (Supple-
mentary Fig. 7c).
Telomere deprotection promotes replication stress lethality.
Mitotic telomere deprotection is regulated by TRF230. While
TRF2 deletion results in the complete loss of telomere protection
and end-to-end chromosome fusions35, partial TRF2 depletion
induces intermediate-state telomeres that activate ATM but
suppress covalent telomere ligation36,37. TRF2 shRNAs of dif-
fering efficiency induce only intermediate-state telomeres
(TRF2 sh-F), or both intermediate-state telomeres and end-to-
end chromosome fusions (TRF2 sh-G)36 in HT1080 6TG cells.
TRF2 depletion and over-expression (TRF2OE) also, respectively,
sensitize and suppress non-canonical mitotic telomere
deprotection30.
To determine if mitotic telomere deprotection impacts
replication stress-induced mitotic death, we created HT1080
6TG TRF2 sh-F and HT1080 6TG TRF2OE cell lines (Fig. 7a).
Cell line characterization identified that TRF2OE and TRF2 sh-F
did not impact genomic DNA replication rates, or cohesion
fatigue induced by replication stress (Supplementary Fig. 8a-c).
Additionally, no telomere fusions occurred with TRF2 sh-F as a
potential source of mitotic arrest38 (Supplementary Fig. 8d–f).
While TRF2 was implicated in peri-centromeric DNA replica-
tion39, we observed no effect of TRF2 sh-F or TRF2OE on
centromeric γ-H2AX foci in APH treated mitotic cells (Supple-
mentary Fig. 8g). These data indicate that the mitotic phenotypes
described below which associate with altered TRF2 expression
result from telomere-specific outcomes.
Consistent with previous observations, TRF2 sh-F induced a
mitotic telomere-specific DDR in the absence of replication
stress36. However, the telomere DDR in TRF2 sh-F cells was
significantly amplified in 1 µM APH treated cells (Fig. 7c, e).
Conversely, TRF2OE suppressed mitotic telomere deprotection in
response to replication stress (Fig. 7d, e). TRF2 sh-F and TRF2OE
had an insignificant or very modest impact on mitotic duration
with 1 µM APH (Supplementary Fig. 8h). However, TRF2 sh-F
significantly reduced the duration of mitotic arrest until cell death
in 1 µM APH treated cultures (Fig. 7f). Additionally, TRF2 sh-F
induced a significant increase in mitotic death in 1 µM APH
treated cells, while TRF2OE conferred a significant suppression of
mitotic death under the same conditions (Fig. 7g). Cumulatively
the data are consistent with mitotic telomere deprotection
contributing to a minor proportion of mitotic death in response
to lethal replication stress.
Discussion
Here we identify that cell death induced by replication stress
occurs predominantly in mitosis through parallel pathways
regulated by WAPL and telomere deprotection (Fig. 8). Further,
we find that suppressing mitotic death promotes distinct cellular
outcomes through diverse mechanisms depending on how the cell
death is averted. As replication stress is a principle driver of
genome instability in oncogenesis9, and many frontline che-
motherapeutics directly or indirectly induce replication stress6,
our findings provide insight into mechanisms of cell death, drug
resistance, and genome evolution during cancer therapy.
Using extended duration live-cell imaging we identified that
lethal replication stress induces SAC-dependent mitotic arrest
and mitotic death in diverse p53-compromised human cell lines.
In asynchronous cultures, cells in G1 at the time of APH
Fig. 5 Type 1 mitotic death is WAPL and BAX/BAK dependent. a Mitotic duration of HT1080 6TG cells treated with APH ± siRNA (three biological
replicates scoring n≥ 429 mitoses per condition are compiled in a Tukey box plot, Mann–Whitney test). b) Outcome of the mitotic events in (a) (mean ± s.
e.m., n= 3 biological replicates, Fisher’s Exact Test). c Representative images of cell division generating micronuclei, or mitotic slippage, in APH treated
HT1080 6TG H2B-mCherry cells. Time is shown as (h:min) relative to the first image in the series. dMitotic outcomes in HT1080 6TG H2B-mCherry cells
treated with APH ±WAPL siRNA or BAX BAK DKO (three biological replicates scoring n= 97 APH, n= 38 APH+WAPL knock down, n= 88 APH+ BAX
BAK DKO cells, Student t-test or Fisher’s Exact test). e Western blots of whole cell extracts from HT1080 6TG BAX BAK DKO cells treated with WAPL or
control siRNA. f Mitotic duration of HT1080 6TG BAX BAK DKO cells treated with APH ± siRNA (three biological replicates scoring n≥ 86 mitoses per
condition are compiled in a Tukey box plot, Mann–Whitney test). g Quantitation of cohesion phenotypes as depicted in Fig. 4b in HT1080 6TG BAX BAK
DKO cells treated with DMSO or APH (mean ± s.e.m, n= 3 biological replicates scoring≥ 50 chromosome spreads per condition, Fisher’s Exact Test).
h Timeline of the experiment shown in (i, j). i Images of DAPI stained nuclei depicting the indicated nuclear phenotypes. j Quantitation of the phenotypes
shown in (i) from HT1080 6TG cells and derivatives at the 72-hour time point as indicated in (h) (n= 3 biological replicates scoring 100 nuclei per
replicate, mean ± s.e.m, Fisher’s exact test). For all panels ns = not significant, **p < 0.01. Scale bars represent 10 µm. Source data are provided as a Source
Data file
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administration, or cells in S/G2 that took greater than 20 h with
APH to enter mitosis, had the highest incidence of mitotic death.
We interpret this result to indicate that replication stress
encountered in early S-phase conferred the greatest probability
for subsequent mitotic lethality. Notably, lethal replication stress
drove mitotic death in the same cell cycle, suggesting mitotic
death is an active process to immediately eliminate compromised
cells in the following mitosis. We anticipate this prevents accu-
mulation of genetically unstable tissue by preventing proliferation
of cells following excessive replication stress.
Replication stress is repaired during mitosis through a
mechanism dependent POLD3, a component of DNA polymerase
δ which is inhibited by APH40–42. However, APH washout failed
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entering mitosis in the following 2 h. Mitotic arrest is therefore
not a result of inhibiting mitotic DNA synthesis. SAC main-
tenance thus resulted from passage of a phenotype induced by
replication stress into mitosis. We suggest this is linked to the
minor cohesion phenotype. In contrast to the moderate and
severe phenotypes, the mild cohesion phenotype was dependent
on replication stress but not mitotic arrest nor microtubule
dynamics. Failure to establish or maintain cohesion at sister
centromeres is expected to impact spindle tension and maintain
the SAC43,44. WAPL depletion simultaneously rescued both the
minor cohesion phenotype and mitotic arrest in replication
stressed cells, consistent with WAPL functioning upstream to
promote mitotic arrest in response to lethal replication stress.
Our observation of two types of mitotic death induced by
replication stress reconciles conflicting reports on cell death
mechanisms during mitotic catastrophe, by indicating that
replication stress simultaneously engages multiple cell death
pathways. The predominant Type 1 pathway was defined by
cohesion fatigue and BAX/BAK-mediated intrinsic apoptosis.
Cytogenetically, we observed that chromosomes in a mitotic cell
typically displayed similar cohesion phenotypes, suggesting that
cohesion fatigue progresses uniformly during replication stress-
induced mitotic arrest. Mitoses with completely separated sister
chromatids accumulated in 1 µM APH treated BAX BAK DKO
cells consistent with a downstream failure to induce apoptosis
following complete cohesion fatigue. We were unable to identify
how cohesion fatigue signals apoptosis. However, one intriguing
possibility is that sudden loss of spindle tension induces signalling
to activate the apoptotic cascade. Because cohesion fatigue
requires microtubule pulling forces, replication stress-induced
mitotic death may differ mechanistically from cell death following
treatment with mitotic poisons that inhibit microtubule
dynamics.
A significant finding of our study is that WAPL plays a major
role mediating replication stress-lethality. We anticipate WAPL
function extends beyond simply driving cohesion fatigue. Cohesin
dynamically interacts with chromatin and stalled replication
forks45, and inhibiting WAPL-dependent Cohesin mobilization
impacts cell viability in budding yeast treated with replication
stress inducing drugs46. WAPL also regulates three-dimensional
genome architecture though chromatin looping47–50, and chro-
matin looping organizes replication origins to facilitate DNA
replication51. Consistent with a more expansive role for WAPL in
regulating replication stress lethality, we observed that WAPL
depletion suppressed both the minor cohesion phenotype and
mitotic arrest in APH or HU treated cells. This indicates WAPL
regulates centromeric cohesion in response to replication stress to
maintain SAC activation in the following mitosis. Future studies
will focus on determining how WAPL cooperates with replication
stress to confer mitotic arrest; potentially through WAPL inter-
action with Cohesin regulators or replication factors at cen-
tromeres, or via WAPL control over chromatin architecture.
We also identified that lethal replication stress induced
telomere-specific DDR signalling. Surprisingly, the mitotic telo-
mere DDR induced by replication stress was resistant to over-
expression of the telomere replication regulator TRF1. Instead,
the telomere DDR resulted from activation of non-canonical
mitotic telomere deprotection. Telomeres sequester the chromo-
some terminus within a t-loop, which when opened in a linear
conformation exposes the DNA end as an ATM activating sub-
strate32. We conclude human telomeres signal mitotic abnorm-
alities induced by genomic DNA replication stress through
alteration of telomere structure to activate DDR signalling. This
discovery expands the role for telomeres in regulating genome
stability to include the selective removal of cells with excessive
genomic DNA replication stress from the cycling population.
Several lines of evidence connect mitotic telomere deprotection
to Type 2 mitotic death and indicate that mitotic telomere
deprotection and cohesion fatigue progress independently during
mitotic arrest. Specifically, WAPL depletion imparted no sig-
nificant impact on Type 2 mitotic death, indicating that Type 2
cell death was independent of cohesion fatigue. In agreement,
augmenting telomere protection by TRF2 overexpression or
depletion affected mitotic death in replication stressed cells
without impacting cohesion phenotypes. Further, the subtle effect
on mitotic death by altering TRF2 expression is consistent with
telomeres contributing to the minor Type 2 pathway. Our
interpretation is that cohesion fatigue and telomere deprotection
occur in parallel during mitotic arrest. This is supported by our
observation of numerous DDR-positive telomeres in cytocen-
trifuged mitotic spreads with completely separated sister chro-
matids. We suggest mitotic death occurs when either cohesion
fatigue or telomere deprotection reaches a signalling threshold
within an individual mitosis. Amplifying telomere deprotection
therefore shortens the mitotic duration to cell death in replication
stressed cells as the aggregate signalling from deprotected telo-
meres increases. Conversely, suppressing telomere deprotection
does not extend mitotic duration when cohesion fatigue remained
active to induce lethality.
In response to lethal replication stress, we found that sup-
pressing apoptosis resulted in mitotic slippage and multilobular
nuclei, whereas WAPL depletion elevated micronuclei. Both
outcomes rescue cell death at the cost of chromosome segregation
errors. Normally, supernumerary chromosomes induce a p53-
dependent growth arrest52. However, p53 inhibition was requisite
for mitotic entry in replication stressed cells. We expect
Fig. 6 Replication stress induces mitotic telomere deprotection. a Experimental time course for (b, c). b Example images of cytocentrifuged chromosome
spreads from HT1080 6TG cells treated with DMSO or APH and stained with DAPI (blue), γ-H2AX immunofluorescence (red) and telomere FISH (green).
c Quantitation of mitotic telomeric and genomic DDR foci in APH or HU treated HT1080 6TG cells (three biological replicates scoring n≥ 81 chromosome
spreads per condition are compiled in a Tukey box plot, Mann–Whitney test). d Western blot of whole cell extracts from HT1080 6TG parental and
HT1080 6TG mCherry-TRF1OE cells. e Representative images of cytocentrifuged chromosomes from HT1080 6TG mCherry-TRF1OE cells treated with
DMSO or APH, stained with DAPI (blue) and γ-H2AX IF (green). f Quantitation of mitotic telomeric DDR foci in HT1080 6TG parental and HT1080 6TG
mCherry-TRF1OE cells (two biological replicates scoring n≥ 48 chromosome spreads per condition are compiled in a Tukey box plot, Mann–Whitney test).
gMitotic duration of HT1080 6TG parental and HT1080 6TG mCherry-TRF1OE cells with DMSO or APH treatment (three biological replicates scoring n≥
57 mitoses per condition compiled in a Tukey box plot, Mann–Whitney test). h Outcome of the mitotic events in (g) (mean ± s.e.m., n= 3 biological
replicates, Fisher’s Exact Test). i Representative images of the mitotic DDR on cytocentrifuged chromosome as shown in (b) for HT1080 6TG cells treated
with APH ± reversine, Hesperadin or KU-55933. j Quantitation of mitotic telomere and genomic DDR foci for the conditions shown in (i) (three biological
replicates scoring n≥ 37 chromosome spreads per condition are compiled in a Tukey box plot, Mann–Whitney test). k Telomere PNA FISH signal intensity
in arbitrary units (A.U.) from individual telomeres in APH treated HT1080 6TG cells, sorted by γ-H2AX status (three biological replicates scoring n≥ 1529
telomeres per condition compiled into a Tukey box plot, Mann–Whitney test). For all panels, ns= not significant, **p < 0.01. Scale bars represent 10 µm.
Source data are provided as a Source Data file
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mutations that enable p53-compromised cells to avoid mitotic
death will impart a substantial selective advantage in response to
replication stress-inducing chemotherapeutics. While WAPL
mutations are observed in cancers, they occur at a lower fre-
quency than mutations in other cohesin subunits53. Notably,
STAG2 is commonly mutated in human malignancies, and
some patient derived STAG2 mutations confer reduced interac-
tion between the STAG2 and WAPL proteins53. We predict
mutations that rescue mitotic death by altering cohesion are more
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Fig. 7 Telomere deprotection contributes to replication stress lethality. a Western blots of whole cell extracts from HT1080 6TG cells stably transduced
with control, TRF2 shRNA (TRF sh-F) or TRF2 over expression (TRF2OE) vectors. b Representative images of cyto-centrifuged chromosome spreads
stained with DAPI (blue), γ-H2AX IF (red) and telomere PNA (green) from control, TRF sh-F or TRF2OE HT1080 6TG cells treated with DMSO or APH.
Scale bar represents 10 µm. c, d Quantitation of mitotic telomere DDR foci from Control sh and TRF2 sh-F cells (c) or vector and TRF2OE cells (d) ± DMSO
or APH (three biological replicates scoring n= 50 mitotic spreads per replicate compiled in a Tukey box plot, Mann–Whitney test). e Difference in the
mean number of mitotic telomeric γ-H2AX foci between HT1080 6TG TRF2 sh-F or TRF2OE cells and their appropriate vector control. These are a different
representation of the same data shown in (c, d) (mean ± s.e.m., n= 3 three biological replications, Student’s t-test). f Mitotic duration to cell death in APH
treated control, TRF2 sh-F and or TRF2OE cells (three biological replicates scoring ≥267 mitotic death events per condition are shown in a dot plot, mean ±
s.e.m., Mann–Whitney test). g Mitotic outcome of control, TRF2 sh-F and TRF2OE cells treated with APH or DMSO (mean ± s.e.m., n= 3 biological
replicates of at least 267 mitoses per condition, Fisher’s Exact Test). For all panels, *p < 0.05, **p < 0.01. Source data are provided as a Source Data file
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persisting in BAX BAK DKO cells after APH treatment are likely
incompatible with efficient proliferation. However, chromosome
segregation errors that induce micronuclei, such as those occur-
ring with rescue of mitotic lethality upon WAPL depletion, are
expected to promote chromosome instability and oncogenic
evolution54. It will be interesting to determine in the future if
mutations in WAPL or its regulatory partners confer resistance to
mitotic death and if this has potential clinical value in cancer
stratification.
Methods
Cell culture and treatments. HT1080 6TG cells were a kind gift from Eric
Stanbridge (University of California, Irvine) and Saos-2 were provided by Roger
Reddel (CMRI). IMR90 cells were purchased from ATCC and IMR90 E6E7 derived
in the Karlseder laboratory. Phoenix cells were purchased from ATCC. Identity of
all cell lines were verified by Cell Bank Australia using short tandem repeat pro-
filing. HT1080 6TG, HeLa, Saos-2 and derivatives were cultured at 37 °C, 10% CO2,
and atmospheric oxygen, in DMEM (Life Technologies) supplemented with 1%
non-essential amino acids (Life Technologies), 1% Glutamax (Life Technologies),
and 10% bovine growth serum (Hyclone). IMR90 and derivatives were cultured at
37 °C, 10% CO2, and 3% O2, in DMEM, supplemented with 1% non-essential
amino acids, 1% Glutamax, 10% fetal bovine serum (Life Technologies). The fol-
lowing compounds were used in cell treatments: dimethyl sulfoxide (DMSO,
Sigma-Aldrich), colcemid (Life Technologies), Taxol (Sigma), reversine (Selleck
Chemicals), KU-55933 (Calbiochem), Hesperadin (Selleck chemicals), Aphidicolin
(Sigma-Aldrich) and Hydroxyurea (Sigma-Aldrich). All cell lines were tested for
mycoplasma contamination (MycoAlert, LT07-118, Lonza) and were found to be
negative.
Viral transduction and cell line generation. High titre, purified pLKO.1 derived
lentiviral vectors, harbouring a non-targeting control shRNA (a gift from David
Sabatini, addgene plasmid #1864), TRF2 sh-F (Open Biosystems,
TRCN0000004811), or TRF2 sh-G (Open Biosystems, TRCN0000018358), were
created in the Salk Institute Gene Transfer, Targeting and Therapeutics (GT3) core,
or the CMRI Vector and Genome Engineering Facility30,55. Cell cultures were
transduced with a MOI of 10 for 48 h, then selected in normal growth media
supplemented with 1 µg ml−1 Puromycin for 5 days. mVenus-hGeminin
(1/110)/pCSII-EF and mCherry-hCdt1(30/120)/pCSII-EF (a kind gift from Atsushi
Miyawaki) were individually packaged into lentivectors using 2nd generation
packaging system, and the viral supernatants were used simultaneously to co-infect
target cells. 3 days post-transduction, cell cultures were sorted at the Salk Institute
flow cytometry core for mVenus fluorescence, allowed to expand for 5 to 7 days,
and sorted again for mCherry fluorescence. Proper progression of red and green
coloration during cell cycling was confirmed with live cell imaging before use in
experimentation.
Retroviral vectors were created by transfecting Phoenix-AMPHO cells with
pWZL-hygro (Vetctor, a gift from Scott Lowe, addgene plasmid #18750), pWZL
Hygro-TRF2 (TRF2OE, a gift from Titia de Lange, addgene plasmid #16066),
pWZL-hTERT (hTERT from pBabe-hTERT, a gift from Titia de Lange, was
recloned into pWZL-hygro), pWZL-H2B-mCherry55, pLPC-mCherry-TRF1
[mCherry was cloned into pLPC-NFLAG TRF1 (a gift from Titia de Lange,
addgene plasmid #16058) by PCR amplification using BamHI restriction sites.
Forward primer: 5′-CGG GGATCC ATG GTG AGC AAG GGC GAG GAGG-3′/
Reverse primer: 5′-CGG GGATCC GGT GGC GAT GCT GCG CTT GTA CAG
CTC GTC CAT GCC-3′ A linker was added in C-terminus of mCherry], pLXSN3
or pLXSN3-p53DD38. Viral supernatants were used to infect HT1080 6TG or
IMR90 cells. Stable vector and TRF2OE cell lines were selected by treatment with
100 µg ml−1 Hygromycin (Invitrogen). HT1080 6TG H2B-mCherry cells were
sorted for mCherry fluorescence at the Salk Institute flow cytometry core facility.
IMR90 TERT were selected with 100 µg ml−1 Hygromycin, followed by second
infection with retrovirus carrying pLXSN3 or pLXSN3-p53DD and selection with
600 µg ml−1 G418 (Nacalai Tesque).
CRISPR/Cas9 gene targeting. BAX BAK DKO HeLa, HT1080 6TG, and HT1080
6TG H2B-mCherry were generated by transiently transfecting with pSpCas9(BB)-
2A-GFP (PX458) plasmids56 (a gift from Feng Zhang; Addgene plasmid #48138)
harbouring guide RNAs targeting human BAX (5′-CTGCAGGATGATTGCCGC
CG) or human BAK (5′-GCATGAAGTCGACCACGAAG) according to the
manufacturer′s protocol (XtremeGene; Sigma-Aldrich). Individual clones were
initially screened for BAX and BAK deletion by immunoblotting, and then con-
firmed by sequencing. Because of their limited proliferation we did not select clonal
IMR90 p53 knockout cells. Instead, we co-transduced a population of IMR90
fibroblasts with a mCherry-Cas9 using FUCas9Cherry (a kind gift from Marco
Herold) and a pool of pKLV-U6gRNA(BbsI)-PGKpuro2ABFP (a gift from Kosuke
Yusa; Addgene plasmid #67974) lentivectors57 carrying six p53 gRNA sequences
(5′-CCCCGGACGATATTGAACAA, 5′-GAGCGCTGCTCAGATAGCGA, 5′-TG
GCCATCTACAAGCAGTCA, 5′-ACTCGGATAAGATGCTGAGG, 5′-GATCCA
CTCACAGTTTCCAT, and 5′-GGTGCCCTATGAGCCGCCTG). Cells were
FACS sorted for BFP and mCherry double positive cells and cultured as above.
siRNA transfection. Control non-targeting (control siRNA, D-001810-10) and
WAPL (L-026287-01) ON-TARGETplus siRNA pools (Dharmacon) were trans-
fected using Lipofectamine RNAi max (Thermofisher Scientific), according to the
manufactures’ protocols.
Live cell imaging and analysis. DIC microscopy was used to visualize mitotic
duration and outcome. These experiments were performed on a Zeiss Cell
Observer inverted wide field microscope, with 20 × 0.8 NA air objective, at 37 °C,
10% CO2 and atmospheric oxygen. Images were captured every 6 min for a
duration up to 65 h using an Axiocam 506 monochromatic camera (Zeiss) and Zen
software (Zeiss). FUCCI live cell imaging was conducted on the same instrument,
using the same imaging duration and protocol, with the addition of a Zeiss HXP
120C mercury short-arc lamp and compatible filter cubes to obtain fluorescent
images. Quantitative live cell imaging of mitotic chromosome dynamics in HT1080
6TG H2B-mCherry cultures and derivatives was done using either combined DIC
and fluorescent imaging on the Zeiss Cell Observer described above with a 40 ×
0.95 NA plan-Apochromat air objective; or on a Zeiss Cell Observer SD spinning
disk confocal microscope imaged using a 561 nm, 50 mW solid state excitation
laser and appropriate filter sets with a 40×, 1.3 NA objective and an Evolve Delta
camera (Photometrics). For these experiments, cells were cultured at 37 °C, 10%
CO2 and atmospheric oxygen and images captured every 3 min for 60 h. For all
movies, mitotic duration was scored by eye and calculated from nuclear envelope
breakdown until cytokinesis or mitotic death. FUCCI Movies were scored by eye,
for G1 (red) and S/G2 (green) by colour, and for mitotic entry, duration and
outcome by cell morphology. Chromosome dynamics in HT1080 6TG-mCherry
H2B were scored by eye. All live cell imaging analysis was done using Zen software.
Visualization of cohesion status and mitotic DDR activation. For cohesion
analysis, standard methanol and acetic acid fixed cytogenetic chromosome spreads
were prepared and stained with fluorescent in situ hybridization (FISH) with a
telomere (Alexa488-OO-ccctaaccctaaccctaa), and centromere (Texas Red-OO-
aaactagacagaagcatt), peptide nucleic acid (PNA) probes (Panagene), by denaturing
at 80 °C, followed by overnight hybridization in a dark humidity chamber58. The
mitotic telomere DDR was visualized using the metaphase-TIF assay58. In this
method, cells were cytocentrifuged onto glass slides, fixed and stained with telo-
mere PNA FISH and immunofluorescence (IF) against γ-H2AX. For both assays,















Fig. 8 Model of replication stress-induced mitotic death. In p53-competent
cells replication stress prevents mitotic entry, while lethal replication stress
induces SAC-dependent mitotic arrest in cells lacking p53 function. With
lethal replication stress WAPL promotes mitotic arrest which drives a
dominant pathway of cell death through cohesion fatigue and BAX/BAK
apoptosis. Non-canonical mitotic telomere deprotection contributes to a
minority of mitotic lethality
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appropriate filter cubes and a CoolCube1 camera (Metasystems). Automated
metaphase finding and image acquisition for these experiments were done using
the MetaSystems imaging platform36.
Cytogenetic and interphase image analysis. Cytogenetic images were analyzed
using Isis software (MetaSystems). For cohesion analysis, images were scored by
eye, and mitotic spreads classified as follows: normal, if <3 chromosomes displayed
visible separated sister chromatids; mild, if ≥3 chromosomes displayed visible sister
chromatids; moderate if ≥3 chromosomes displayed centromere cohesion loss but
retained distal chromosome arm cohesion; severe if ≥3 chromosomes displayed
complete sister chromatid separation. In practice, we typically observed the
majority of chromosomes in a mitotic spread displayed the same cohesion status.
Mitotic DDR foci were quantified by eye using Isis software, and classified as
telomeric if the γ-H2AX IF focus colocalized with a telomere PNA signal. To
determine relative telomere lengths at DDR(+) and DDR(−) chromosome ends,
telomere signals were captured at fixed exposure time as described above, and
images were analyzed using Imaris software version 8.2 (BitPlane). Images were
segmented using the mitotic chromosomes as a region of interest, and the telo-
meres were detected as spots using the spot detection wizard. Telomere colocali-
zation with γ-H2AX foci were identified using the co-localisation tool. The sum
fluorescence intensity was determined for each telomere in the γ-H2AX colocalised
(DDR+) and the γ-H2AX excluded (DDR−) cohorts. To assay interphase nuclei
for micronuclei and multilobular cells, cultures were grown, treated and fixed on
Alcain blue treated glass coverslips, stained with DAPI, washed, mounted and
imaged using a on a Zeiss AxioImager Z.2 with a 63× 1.4 NA oil objective using
Zen software. Images were scored by eye.
Chromatin fibre analysis. Replication rates were measured using chromatin fibre
analysis59. Briefly, unsynchronized cells are sequentially pulse-labelled with 100 μM
of thymidine analogues (IdU then CldU) for 30 min each. After harvesting,
the genomic DNA was stretched as fibres onto glass slides at a constant rate of
2 kb μm−1 using a molecular combing system (Genomic Vision). Nascent DNA
replication was visualized by IF against IdU and CldU and captured using Zen
software and a Zeiss AxioImager Z.2, with a 63×, 1.4 NA oil objective, appropriate
filter cubes and an Axiocam 506 monochromatic camera (Zeiss). In our analysis,
only replication forks with a visible origin of replication, and both IdU and CLdU
staining were scored. Replication rates were calculated based solely on the IdU
tracks, which result from the first pulse of nucleoside analogue. The length of IdU
fibres were converted to kilobasepairs according to a constant and sequence-
independent stretching factor (1 μm= 2 Kb) using Zen software.
Western blotting. Preparation of whole cell extracts and western blots were
performed32 and luminescence was visualized on an LAS 4000 Imager (Fujifilm).
Antibodies. Primary antibodies used in this study: γ-H2AX (1:1000, 05-636,
Millipore), TRF1 (1:500, sc-56807, Santa Cruz), TRF2 (1:1000, NB110-57130,
Novus Biologicals), WAPL (1:1000, SC-365189, Santa Cruz), β-actin (1:10,000,
A5441, Sigma), BAX (1:1000, rat monoclonal 49F9; WEHI monoclonal antibody
facility), BAK (1:2000, rabbit polyclonal B5897, Sigma), CldU (1:25, 6326, Abcam),
IdU (1:5, 347580, BD Biosciences), p53 (p53 (DO-1): 1:200, sc-126, Santacruz),
p53-ser10 (1:1000, 9284S, Cell Signalling), Vinculin (1:10,000, V9131, Sigma).
Secondary antibodies used in this study: Alexa Fluor 568-Goat anti-mouse IgG
(1:1000, A-11031, Thermo Fisher Scientific), Alexa Fluor 488-Goat anti-mouse
(1:1000, A11029, Thermo Fisher Scientific) and Alexa Flour 594-Goat anti-rat IgG
(1:1000, A-11007). Goat anti-Rabbit HRP (1:1000, P0448, Dako), Goat anti-Mouse
HRP (1:1000, P0447, Dako).
Statistics and Figure preparation. Statistical analysis was performed using
GraphPad Prism. Box plots are displayed using the Tukey method where the box
extends from the 25th to the 75th percentile data points and the line represents the
median. The upper whisker represents data points ranging up to the 75th percentile
+ (1.5 × the inner quartile range), or the largest value data point if no data points
are outside this range. The lower whisker represents data points ranging down to
the 25th percentile− (1.5 × the inner quartile range), or the smallest data point if
no data points are outside this range. Data points outside these ranges are shown as
individual points. Error bars, statistical methods and n, are described in figure
legends. In Fig. 5d statistical significance was determined by a t-test for all con-
ditions expect mitotic slippage, where a Fisher’s exact test was applied. This is
because a t-test cannot be used when all outcomes are zero for two of the condi-
tions. Figures were prepared using Adobe Photoshop and Illustrator.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are archived at the Children’s Medical
Research Institute, Kyoto University, or the Walter and Eliza Hall Institute of Medical
Research, and are available from the corresponding author upon reasonable request. The
source data underlying all the presented western blots, histograms, and dot plots are
available in the Source Data file.
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